BDRX News and Press, Biodexa Pharmaceuticals PLC-ADR From 12/09/25

A look at the top 10 most actives in the United States Netcapital Inc. (NCPL) rose 105.0% to $1.3506 on volume of 269,304,576 shares Paranovus Entertainment Technology Ltd. (PAVS) fell 14.0% to $0.04205 on volume of 211,406,068 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose ...

A look at the top 10 most actives in the United States Paranovus Entertainment Technology Ltd. (PAVS) rose 33.6% to $0.0489 on volume of 1,320,857,302 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 2.7% to $2.93 on volume of 288,725,865 shares NVIDIA Corporation (NVDA) rose ...

A look at the top 10 most actives in the United States Paranovus Entertainment Technology Ltd. (PAVS) rose 28.7% to $0.0471 on volume of 1,267,429,086 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 1.3% to $2.9699 on volume of 260,909,941 shares NVIDIA Corporation (NVDA) ros...

December 1, 2025 Biodexa Announces Enrolment of First European Patients into Pivotal Phase 3 Serenta Trial in FAP Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipelin...

November 24, 2025 Biodexa Activates First European Site for Registrational Phase 3 Serenta Trial in FAP Biodexa Pharmaceuticals PLC (Nasdaq: BDRX) announced today that the University of Bonn, Germany is now actively screening patients for the Phase 3 Serenta clinical trial evaluat...

November 3, 2025 Biodexa Announces Approval of CTA in Europe for Phase 3 Serenta Trial in FAP First European patient expected to be enrolled in 4Q 2025 Addressable US - European Market Put at $7 Billion Biodexa Pharmaceuticals PLC (“Biodexa” or “th...

A look at the top 10 most actives in the United States AiRWA Inc. (YYAI) rose 8.3% to $0.209 on volume of 775,237,685 shares EPWK Holdings Ltd. (EPWK) rose 52.5% to $0.1148 on volume of 756,638,089 shares AtlasClear Holdings Inc. (ATCH) rose 37.6% to $0.5 on volume of 420,835,167 shares N...

October 6, 2025 Biodexa to Host Breakfast Symposium on FAP Mechanisms and Chemoprevention Trial Issues at CGA – IGC Conference on October 11, 2025 Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical st...

2025-09-26 17:31:39 ET More on Biodexa Pharmaceuticals Seeking Alpha’s Quant Rating on Biodexa Pharmaceuticals Historical earnings data for Biodexa Pharmaceuticals Financial information for Biodexa Pharmaceuticals Read the full article on Seeking Alp...

2025-09-12 14:11:54 ET More on Biodexa Pharmaceuticals Seeking Alpha’s Quant Rating on Biodexa Pharmaceuticals Historical earnings data for Biodexa Pharmaceuticals Financial information for Biodexa Pharmaceuticals Read the full article on Seeking Alp...